Speaking during his first visit to the United Kingdom in his new role, Porter said: "The UK has always been an important market for Orion Health globally and we remain committed to our UK partners and customers."
Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C.
In our sector, problems are pretty much inevitable. Think about it. Healthcare technology is tricky stuff.